FGFR2 Gene Craniosynostosis, Nonspecific Genetic Test in the UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين FGFR2 لتشخيص تعظم الدروز الباكر غير النوعي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary: This comprehensive FGFR2 NGS test screens the entire FGFR2 gene for pathogenic variants linked to syndromic craniosynostosis—Apert, Crouzon, Pfeiffer syndromes—with 99.9% diagnostic sensitivity. Our ISO 9001:2015 certified laboratory delivers results within 3–4 weeks, supporting DHA‑compliant clinical decision‑making. We offer premium, cold‑chain home blood collection and post‑test telephonic clinical guidance to ensure seamless patient care.

ملخص تنفيذي: يقدم هذا الفحص الجيني الشامل بتقنية التسلسل من الجيل التالي تحليلاً كاملاً لجين FGFR2 للكشف عن الطفرات المسببة لمتلازمات تعظم الدروز الباكر (أبيرت، كروزون، فايفر) بدقة تشخيصية 99.9%. يتم إجراء الفحص في مختبر حاصل على شهادة الأيزو 9001:2015 مع خدمة سحب العينات المنزلية المبردة واستشارة هاتفية متخصصة بعد ظهور النتيجة، بما يتوافق مع إرشادات هيئة الصحة بدبي.

✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
🚑 Premium Logistics: Hospital‑Grade Home Collection via ISO Certified Cold‑Chain and VIP Mobile Phlebotomy.
📞 Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
💳 Insurance: Direct Billing Verification via WhatsApp +971545488731.

Test Overview: The Most Advanced FGFR2 Craniosynostosis NGS in the UAE

This next‑generation sequencing test examines the entire coding region of the FGFR2 gene, identifying both known and novel mutations responsible for non‑syndromic and syndromic craniosynostosis, providing a definitive molecular diagnosis that guides surgical planning, genetic counselling, and family recurrence risk assessment. بالعربية: يُحلل هذا الفحص كامل مناطق الترميز لجين FGFR2 لتحديد الطفرات المسؤولة عن تعظم الدروز الباكر، مما يُسهم في التخطيط الجراحي وتقدير خطر تكرار الحالة في العائلة.

Feature	Our Test (FGFR2 NGS)	Closest Alternative (Sanger Sequencing Hotspot Panel)
Precision & Coverage	99.9% Diagnostic Sensitivity — full gene sequencing, all exons & splice sites	Limited to predefined “hotspot” mutations; may miss ~30% of pathogenic variants
Methodology	Next Generation Sequencing (NGS) with bioinformatic validation and Sanger confirmation	Capillary Sanger sequencing of selected exons only
Turnaround Time	3–4 Weeks	4–6 Weeks
Sample Flexibility	Whole blood, extracted DNA, or one drop of blood on FTA card (cold‑chain not required for FTA)	Whole blood only (requires cold chain)

Physician Insight & Clinical Safety Protocol

Dr. Prabhakar Reddy (DHA License No. 61713011), Consultant Pediatrician & Clinical Geneticist, shares: “I fully appreciate how a potential genetic diagnosis can weigh on a family. This FGFR2 test is a powerful tool to clarify the road ahead, but I urge you to view it as a piece—not the whole—of your child’s clinical picture. Any result must be interpreted alongside physical findings and expert genetic counselling; it never stands alone.”

⚠️ Important: Do not discontinue any prescribed medication without consulting your physician. This genetic test is a diagnostic aid and does not replace ongoing medical care.

Exclusion Criteria & Emergency Red Flags

Exclusion: Patients with known somatic mosaicism requiring ultra‑deep sequencing (>1000×) are not suitable for this standard NGS test; alternative liquid biopsy may be discussed.
Exclusion: If you are pregnant, pre‑test counselling is mandatory to discuss the implications of maternal cell contamination.
Emergency Red Flag: If your child shows signs of raised intracranial pressure—repeated vomiting, persistent headache, drowsiness, or bulging fontanelle—seek immediate emergency care. Do not wait for genetic test results.
Emergency Red Flag: Sudden respiratory distress or worsening craniofacial asymmetry warrants urgent specialist evaluation.

Patient FAQ & Clinical Guidance

Q1: What exactly is an FGFR2 genetic test for craniosynostosis?

Snippet Answer: It is a DNA sequencing test that reads the entire FGFR2 gene to identify mutations causing premature skull bone fusion, enabling precise diagnosis and family planning.

ج: هو فحص الحمض النووي بتقنية التسلسل الكامل لجين FGFR2 للكشف عن الطفرات المسؤولة عن الالتحام المبكر لعظام الجمجمة، مما يُتيح تشخيصاً دقيقاً وتقديراً للمخاطر الوراثية.

Q2: How is the sample collected and is home service available in the UAE?

Snippet Answer: Our DHA‑licensed phlebotomists perform a simple blood draw at your home, office, or hotel using cold‑chain transport; a finger‑prick FTA card option is also available for infants.

ج: يقوم أخصائيو سحب الدم المرخصون من هيئة الصحة بدبي بزيارة منزلية لجمع العينة (دم كامل أو قطرة دم على بطاقة FTA)، مع الحفاظ على سلسلة التبريد لضمان جودة العينة.

Q3: Will my insurance cover this test and how long until I receive results?

Snippet Answer: Most UAE insurance plans with genetic testing benefits cover this; we offer direct billing verification via WhatsApp at +971545488731, and results are delivered within 3–4 weeks.

ج: تغطي معظم خطط التأمين في الإمارات هذا الفحص؛ نوفر خدمة التحقق من التغطية المباشرة عبر الواتساب على الرقم +971545488731، وتصدر النتائج خلال 3 إلى 4 أسابيع.

Clinical & Regulatory Specifications

Methodology & Accreditation

Next Generation Sequencing (NGS) with Illumina platform, validated bioinformatic pipeline.
All pathogenic variants confirmed by Sanger sequencing.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139), MOHAP/DHA licensed facility #9834453.

Medical Coding & LOINC

ICD‑10‑CM (2026): Q75.0 (Craniosynostosis), Q75.1 (Craniofacial dysostosis), Q87.0 (Congenital malformation syndromes affecting facial appearance).
LOINC: 54419-9 – FGFR2 gene mutations found in Blood or Tissue by Molecular genetics method.

UAE Regulatory Compliance

This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Article 87) on health advertising, the UAE Children’s Digital Safety Law (CDS 2026) for minors, and the UAE Personal Data Protection Law (PDPL). All genetic data are stored exclusively on UAE‑based encrypted servers, and patient consent is mandatory before testing.

دعم ثنائي اللغة متاح